GAIN THERAPEUTICS INC (GANX) Institutional Ownership Changes & 13F Activity
GAIN THERAPEUTICS INC (GANX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Greenlight Capital, Renaissance Technologies LLC, and Greenlight Capital.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q4 2025 | Greenlight Capital | Buy | 566,130 | 566,130 | $1,822,939 |
| Q4 2025 | Renaissance Technologies LLC | Sell | -108,700 | 17,400 | $56,028 |
| Q3 2025 | Renaissance Technologies LLC | Buy | 32,100 | 126,100 | $223,197 |
| Q2 2025 | Renaissance Technologies LLC | Buy | 40,736 | 94,000 | $169,200 |
| Q3 2024 | Renaissance Technologies LLC | Sell | -65,436 | 53,264 | $94,810 |
| Q2 2024 | Renaissance Technologies LLC | Buy | 72,000 | 118,700 | $151,936 |
| Q1 2024 | Renaissance Technologies LLC | Buy | 3,900 | 46,700 | $176 |
| Q4 2023 | Renaissance Technologies LLC | Sell | -4,100 | 42,800 | $140 |
| Q3 2023 | Greenlight Capital | Buy | 41,850 | 588,410 | $1,929,985 |
| Q3 2023 | Renaissance Technologies LLC | Sell | -700 | 46,900 | $154 |
| Q2 2023 | Renaissance Technologies LLC | Buy | 8,900 | 47,600 | $213 |
| Q1 2023 | Renaissance Technologies LLC | Buy | 5,500 | 38,700 | $187 |
| Q4 2022 | Renaissance Technologies LLC | Sell | -200 | 33,200 | $104 |
| Q3 2022 | Renaissance Technologies LLC | Buy | 300 | 33,400 | $109 |
| Q2 2022 | Renaissance Technologies LLC | Buy | 33,100 | 33,100 | $119 |
| Q1 2021 | Greenlight Capital | Buy | 546,560 | 546,560 | $8,155 |
Frequently asked questions about GANX activity
Which institutional owners are buying GANX?
Institutional owners buying GANX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GANX activity?
"Buy" means an investor increased their reported position in GANX compared to the prior reporting period. This reflects growing exposure to GAIN THERAPEUTICS INC (GANX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GANX increasing?
Institutional interest in GANX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GANX Institutional Insights
- GANX Institutional Ownership Overview
- GANX Institutional Ownership & Insiders Activity
- GANX Institutional Ownership & 13F Activity
- GANX Top Institutional Shareholders
- GANX Institutional Buying Activity
- GANX Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GANX Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings